FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Davies

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Phenomena

Phosphorylation

Procedures

Living Beings

Physiology

Brain Chemistry

Co-author Network

Publications

TOP 3
Ute Dreses-Werringloer; Pallavi Chandakkar; Peter Davies; Valérie Vingtdeux; Haitian Zhao; Philippe Marambaud
CALHM1 controls the Ca2+-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
Cristina D'Abramo; Christopher M Acker; Heidy T Jimenez; Peter Davies
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity.
Stefanie K Forest; Christopher M Acker; Cristina D'Abramo; Peter Davies
Methods for measuring tau pathology in transgenic mouse models.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Davies (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ute Dreses-Werringloer; Pallavi Chandakkar; Peter Davies; Valérie Vingtdeux; Haitian Zhao; Philippe Marambaud
CALHM1 controls the Ca2+-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
Journal of cell science 2013;126(Pt 5):1199-206.
2013: Cristina D'Abramo; Christopher M Acker; Heidy T Jimenez; Peter Davies
Tau Passive Immunotherapy in Mutant P301L Mice: Antibody Affinity versus Specificity.
PloS one 2013;8(4):e62402.
2013: Stefanie K Forest; Christopher M Acker; Cristina D'Abramo; Peter Davies
Methods for measuring tau pathology in transgenic mouse models.
Journal of Alzheimer's disease : JAD 2013;33(2):463-71.
2013: Christopher M Acker; Peter Davies; Stefanie K Forest; Ray Zinkowski; Cristina D'Abramo
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models.
Neurobiology of aging 2013;34(1):338-50.
2012: Brady C Kirchberg; Jeremy Koppel; Jesus J Gomar; Marc Gordon; Margarita B Adelsky; Justin J Buthorn; Erica Christen; Jessica R Cohen; Concepcion Conejero-Goldberg; Peter Davies; Terry Goldberg
Semantic distance abnormalities in mild cognitive impairment: their nature and relationship to function.
The American journal of psychiatry 2012;169(12):1275-83.
2012: Hemachander Capiralla; Peter Davies; Ute Dreses-Werringloer; Jeganathan Venkatesh; Valérie Vingtdeux; Haitian Zhao; Philippe Marambaud
Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages.
The FEBS journal 2012;279(20):3791-9.
2012: Jason G Weinger; Vladislav Tsiperson; Christopher M Acker; Ashrei Bayewitz; Celia F Brosnan; Peter Davies; Bridget Shafit-Zagardo
Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Journal of neuropathology and experimental neurology 2012;71(5):422-33.
2012: Hemachander Capiralla; Yousef Al-Abed; Roman Sankowski; Haitian Zhao; Peter Davies; Valérie Vingtdeux; Philippe Marambaud
Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade.
Journal of neurochemistry 2012;120(3):461-72.
2012: Sarah D Schlatterer; Hyeon-Sook Suh; Sunhee C Lee; Christopher M Acker; Shufen Chen; Concepcion Conejero-Goldberg; Peter Davies
Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways.
Journal of neuroinflammation 2012;9():208.
2012: Stefani N Thomas; Yunhu Wan; Jeff Kuret; Peter Davies; Kristen E Funk; Zhongping Liao; Austin Yang
Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach.
Acta neuropathologica 2012;123(1):105-17.
2012: Julien Chapuis; Peter Davies; Hemachander Capiralla; Valérie Vingtdeux; Philippe Marambaud
Gas1 interferes with AβPP trafficking by facilitating the accumulation of immature AβPP in endoplasmic reticulum-associated raft subdomains.
Journal of Alzheimer's disease : JAD 2012;28(1):127-35.
2011: Jesus J Gomar; Philip D Harvey; Maria T Bobes-Bascaran; Peter Davies; Terry Goldberg
Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2011;19(11):915-22.
2011: Sarah D Schlatterer; Christopher M Acker; Peter Davies
c-Abl in neurodegenerative disease.
Journal of molecular neuroscience : MN 2011;45(3):445-52.
2011: Xiyun Chai; Nicola Buckner; Claire V Cella; Peter Davies; Jenna Hanmer; Michael Hutton; Robert Kinley; Tracey K Murray; Michael J O'Neill; Helen Sims; Su Wu; Martin Citron
Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression.
The Journal of biological chemistry 2011;286(39):34457-67.
2011: Jesus J Gomar; Maria T Bobes-Bascaran; Concepcion Conejero-Goldberg; Peter Davies; Terry Goldberg
Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
Archives of general psychiatry 2011;68(9):961-9.
2011: Valérie Vingtdeux; Haitian Zhao; Pallavi Chandakkar; Peter Davies; Philippe Marambaud
Small-molecule activators of AMP-activated protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis.
Molecular medicine (Cambridge, Mass.) 2011;17(9-10):1022-30.
2011: Jeremy Koppel; Dan Rujescu; Valérie Vingtdeux; Fabien Campagne; Julien Chapuis; Erica Christen; Peter Davies; Ute Dreses-Werringloer; Michael Ewers; Marc Gordon; Blaine Greenwald; Harald Hampel; Philippe Marambaud
CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
Molecular medicine (Cambridge, Mass.) 2011;17(9-10):974-9.
2011: Allal Boutajangout; Peter Davies; Johanna Ingadottir; Einar Sigurdsson
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.
Journal of neurochemistry 2011;118(4):658-67.
2011: Concepcion Conejero-Goldberg; Peter Davies; Ute Dreses-Werringloer; M M Herman; T M Hyde; J E Kleinman; S Chen; Terry Goldberg
Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.
Molecular psychiatry 2011;16(8):836-47.
2011: Julien Chapuis; Valérie Vingtdeux; Fabien Campagne; Peter Davies; Philippe Marambaud
Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein.
Human molecular genetics 2011;20(10):2026-36.
2011: Valérie Vingtdeux; Peter Davies; dennis dickson; Philippe Marambaud
AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
Acta neuropathologica 2011;121(3):337-49.
2011: Sarah D Schlatterer; Matthew A Tremblay; Christopher M Acker; Peter Davies
Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain.
Journal of Alzheimer's disease : JAD 2011;25(1):119-33.
2011: Valérie Vingtdeux; Pallavi Chandakkar; Haitian Zhao; Cristina d'Abramo; Peter Davies; Philippe Marambaud
Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011;25(1):219-31.
2010: Terry Goldberg; Jeremy Koppel; Lynda Keehlisen; Erica Christen; Ute Dreses-Werringloer; Concepcion Conejero-Goldberg; Marc Gordon; Peter Davies
Performance-based measures of everyday function in mild cognitive impairment.
The American journal of psychiatry 2010;167(7):845-53.
2010: Parastoo Momeni; Karen DeTucci; Richard E Straub; Daniel R Weinberger; Peter Davies; Jordan Grafman; John Hardy; Edward D Huey
Progranulin (GRN) in two siblings of a Latino family and in other patients with schizophrenia.
Neurocase 2010;16(3):273-9.
2010: Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.
The Journal of biological chemistry 2010;285(12):9100-13.
2010: Shufen Chen; Kirk Townsend; Terry Goldberg; Peter Davies; Concepcion Conejero-Goldberg
MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants.
Journal of Alzheimer's disease : JAD 2010;22(4):1313-29.
2010: Luca Giliberto; Cristina d'Abramo; Christopher Michael Acker; Peter Davies; Luciano D'Adamio
Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivo.
PloS one 2010;5(7):e11609.
2010: Matthew A Tremblay; Christopher M Acker; Peter Davies
Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.
Journal of Alzheimer's disease : JAD 2010;19(2):721-33.
2010: Leonel Rojo; Jans Alzate-Morales; Iván N Saavedra; Peter Davies; Ricardo B Maccioni
Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2010;19(2):573-89.
2009: Manuela Polydoro; Christopher M Acker; karen duff; Pablo E Castillo; Peter Davies
Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009;29(34):10741-9.
2009: Shuxin Hu; Aynun N Begum; Mychica R Jones; Mike S Oh; Walter K Beech; Beverly Hudspeth Beech; Fusheng Yang; Pingping Chen; Oliver J Ubeda; Peter C Kim; Peter Davies; qiulan ma; Gregory M. Cole; Sally A Frautschy
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals.
Neurobiology of disease 2009;33(2):193-206.
2009: Peter Davies; Jeremy Koppel
Mechanism-based treatments for Alzheimer's disease.
Dialogues in clinical neuroscience 2009;11(2):159-69.
2009: Jeremy Koppel; Heather B Bradshaw; Terry Goldberg; Houman Khalili; Philippe Marambaud; Michael J Walker; Miguel Pazos; Marc Gordon; Erica Christen; Peter Davies
Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study.
Lipids in health and disease 2009;8():2.
2008: Emmanuel Planel; Pavan Krishnamurthy; Tomohiro Miyasaka; Li Liu; Mathieu Herman; Asok Kumar; Alexis Bretteville; Helen Y Figueroa; Wai Haung Yu; Robert A Whittington; Peter Davies; Akihiko Takashima; Ralph A. Nixon; karen duff
Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(48):12798-807.
2008: Jeremy Koppel; Peter Davies
Targeting the endocannabinoid system in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2008;15(3):495-504.
2008: Ute Dreses-Werringloer; jean-charles lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; D M A Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
Cell 2008;133(7):1149-61.
2008: Concepcion Conejero-Goldberg; Kirk Townsend; Peter Davies
Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells.
Journal of molecular neuroscience : MN 2008;35(2):143-50.
2008: Marisol Espinoza; Rohan de Silva; dennis dickson; Peter Davies
Differential incorporation of tau isoforms in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2008;14(1):1-16.
2008: Howard A Crystal; Peter Davies
Toward a plasma marker for Alzheimer disease: some progress, but still a long way to go.
Neurology 2008;70(8):586-7.
2008: Valérie Vingtdeux; Ute Dreses-Werringloer; Haitian Zhao; Peter Davies; Philippe Marambaud
Therapeutic potential of resveratrol in Alzheimer's disease.
BMC neuroscience 2008;9 Suppl 2():S6.
2008: Haitian Zhao; Ute Dreses-Werringloer; Peter Davies; Philippe Marambaud
Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants.
BMC research notes 2008;1():38.
2008: Concepcion Conejero-Goldberg; Peter Davies; Luis Ulloa
Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.
Neuroscience and biobehavioral reviews 2008;32(4):693-706.
2007: Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael Hutton; dennis dickson
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.
Annals of neurology 2007;61(5):435-45.
2007: Kevin Park; Janice L Hallows; Paramita Chakrabarty; Peter Davies; Inez Vincent
Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(11):2969-78.
2007: Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph E Parisi; Bradley Boeve; David S. Knopman; Ronald C. Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael Hutton; dennis dickson
Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.
Journal of neuropathology and experimental neurology 2007;66(2):142-51.
2007: Vahram Haroutunian; Peter Davies; C Vianna; Joseph Buxbaum; Dushyant P Purohit
Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
Neurobiology of aging 2007;28(1):1-7.
2006: Gerald P Gellermann; Thomas R Appel; Peter Davies; Stephan Diekmann
Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingolipids.
Biological chemistry 2006;387(9):1267-74.
2006: Cristina D'Abramo; Roberta Ricciarelli; MARIA ADELAIDE PRONZATO; Peter Davies
Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells.
Journal of neurochemistry 2006;98(4):1068-77.
2006: A Z Herskovits; Peter Davies
The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer's disease.
Neurobiology of disease 2006;23(2):398-408.
2006: Donald A Siegel; Peter Davies; Kostantin Dobrenis; May Huang
Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain.
Journal of neurochemistry 2006;98(1):34-44.
2006: Martin von Bergen; Stefan Barghorn; Shirley A Müller; Marcus Pickhardt; Jacek Biernat; Eva-Maria Mandelkow; Peter Davies; Ueli Aebi; Eckhard Mandelkow
The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.
Biochemistry 2006;45(20):6446-57.
2006: Diane Cripps; Stefani N Thomas; Young Jeng; Frank Yang; Peter Davies; Austin Yang
Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation.
The Journal of biological chemistry 2006;281(16):10825-38.
2006: Rohan de Silva; Tammaryn Lashley; Catherine Strand; Anna-Maria Shiarli; Jing Shi; Jinzhou Tian; Kathryn L Bailey; Peter Davies; Eileen H Bigio; Kunimasa Arima; Eizo Iseki; Shigeo Murayama; Hans A Kretzschmar; Manuela Neumann; Carol F Lippa; Glenda Halliday; James MacKenzie; Rivka Ravid; dennis dickson; Zbigniew K Wszolek; Takeshi Iwatsubo; Stuart Pickering-Brown; Janice Holton; Andrew J Lees; Tamas Revesz; D M A Mann
An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.
Acta neuropathologica 2006;111(4):329-40.
2006: Mony J de Leon; Susan Desanti; Raymond Zinkowski; Pankaj D Mehta; Domenico Pratico'; S Segal; Henry Rusinek; Juan Li; Wai Hon Tsui; LA Saint Louis; C M Clark; Chaim Y Tarshish; Yongsheng Li; L Lair; Elizabeth Javier; Kenneth Rich; P Lesbre; Lisa Mosconi; Barry Reisberg; Martin Sadowski; J F DeBernadis; Daniel Kerkman; Harald Hampel; Lars-Olof Wahlund; Peter Davies
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.
Neurobiology of aging 2006;27(3):394-401.
2006: Peter Davies
A long trek down the pathways of cell death in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2006;9(3 Suppl):265-9.
2005: Philippe Marambaud; Haitian Zhao; Peter Davies
Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.
The Journal of biological chemistry 2005;280(45):37377-82.
2005: Shuji Matsuda; Luca Giliberto; Yukiko Matsuda; Peter Davies; Eileen McGowan; Fiona Pickford; Jorge Ghiso; Blas Frangione; Luciano D'Adamio
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.
The Journal of biological chemistry 2005;280(32):28912-6.
2005: Peter Davies
Tribute to Robert Terry.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2005;1(1):81.
2005: Cathy Andorfer; Christopher M Acker; Yvonne Kress; Patrick R Hof; karen duff; Peter Davies
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(22):5446-54.
2005: Dengshun Wang; richard lipton; Mindy Katz; Peter Davies; Herman Buschke; Gail Kuslansky; Joe Verghese; Steven G Younkin; Christopher B Eckman; dennis dickson
Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging.
Journal of neuropathology and experimental neurology 2005;64(5):378-85.
2005: Harald Hampel; Katharina Bürger; Jens C Pruessner; Raymond Zinkowski; John DeBernardis; Daniel Kerkman; Gerda Leinsinger; Alan C Evans; Peter Davies; Hans-Jürgen Möller; Stefan J Teipel
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease.
Archives of neurology 2005;62(5):770-3.
2005: A Z Herskovits; Peter Davies
Generation and characterization of monoclonal antibodies to human PCTAIRE 3.
Hybridoma (2005) 2005;24(2):98-105.
2005: Yasuhiro Fujino; Dengshun Wang; Natalie Thomas; Marisol Espinoza; Peter Davies; dennis dickson
Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.
Journal of neuropathology and experimental neurology 2005;64(3):209-14.
2005: Gorazd B Stokin; Concepcion Lillo; Tomás L Falzone; Richard G Brusch; Edward Rockenstein; Stephanie L Mount; Rema Raman; Peter Davies; Eliezer Masliah; David S Williams; Lawrence S B Goldstein
Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.
Science (New York, N.Y.) 2005;307(5713):1282-8.
2005: Tatyana Tchaikovskaya; Vadim Fraifeld; Tinatin Urphanishvili; John H Andorfer; Peter Davies; Irving Listowsky
Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease.
Mechanisms of ageing and development 2005;126(2):309-15.
2004: Mark A Lovell; Shuling Xiong; Chengsong Xie; Peter Davies; William R Markesbery
Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3.
Journal of Alzheimer's disease : JAD 2004;6(6):659-71; discussion 673-81.
2004: Y Fujino; Michael W DeLucia; Peter Davies; dennis dickson
Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity.
Neuropathology and applied neurobiology 2004;30(6):676-82.
2004: Jun Yao; Suzana Petanceska; Thomas J Montine; David M Holtzman; Stephen D Schmidt; Carolyn A Parker; Michael J Callahan; William J Lipinski; Charles L Bisgaier; Brian A Turner; Ralph A. Nixon; Ralph N Martins; Charles Ouimet; Jonathan D. Smith; Peter Davies; Eugene Laska; Michelle E Ehrlich; Lary Walker; Paul Mathews; Sam Gandy
Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Journal of neurochemistry 2004;90(4):1011-8.
2004: Chris Conrad; Cintia Vianna; Christian Schultz; Dietmar R Thal; Estifanos Ghebremedhin; Jack Lenz; Heiko Braak; Peter Davies
Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease.
Journal of neurochemistry 2004;89(1):179-88.
2004: A Z Herskovits; Peter Davies
Cloning and expression analysis of two novel PCTAIRE 3 transcripts from human brain.
Gene 2004;328():59-67.
2004: Stefan Barghorn; Peter Davies; Eckhard Mandelkow
Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain.
Biochemistry 2004;43(6):1694-703.
2004: Harald Hampel; Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Alexander Goernitz; Niels Andreasen; Magnus Sjoegren; John DeBernardis; Daniel Kerkman; Koichi Ishiguro; Hideto Ohno; Eugeen Vanmechelen; hugo vanderstichele; Cheryl McCulloch; Hans-Jurgen Moller; Peter Davies; Kaj Blennow
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Archives of general psychiatry 2004;61(1):95-102.
2003: Pankajavalli Ramakrishnan; dennis dickson; Peter Davies
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies.
Neurobiology of disease 2003;14(2):251-64.
2003: Meir H Scheinfeld; Enrico Ghersi; Peter Davies; Luciano D'Adamio
Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1.
The Journal of biological chemistry 2003;278(43):42058-63.
2003: Marion Hogg; Zoran M Grujic; Matt Baker; Serpil Demirci; Angela L Guillozet; Alison P Sweet; Laura L Herzog; Sandra Weintraub; Marek-Marsel Mesulam; Nichole E LaPointe; T Chris Gamblin; Robert W Berry; Lester I Binder; Rohan de Silva; Andrew J Lees; Marisol Espinoza; Peter Davies; Andrew Grover; Naruhiko Sahara; Takashi Ishizawa; dennis dickson; Shu-Hui C. Yen; Michael Hutton; Eileen H Bigio
The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
Acta neuropathologica 2003;106(4):323-36.
2003: Cathy Andorfer; Yvonne Kress; Marisol Espinoza; Rohan de Silva; Kerry L Tucker; Yves-Alain Barde; karen duff; Peter Davies
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
Journal of neurochemistry 2003;86(3):582-90.
2003: Anurag Tandon; Haung Yu; Linda Wang; Ekaterina Rogaeva; Christine Sato; M Azhar Chishti; Toshitaka Kawarai; Hiroshi Hasegawa; Fusheng Chen; Peter Davies; Paul E Fraser; David Westaway; Peter St George-Hyslop
Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles.
Journal of neurochemistry 2003;86(3):572-81.
2003: Wendy Noble; Vicki Olm; Kazuyuki Takata; Evelyn Casey; O Mary; Jordana Meyerson; Kate Gaynor; John LaFrancois; Lili Wang; Takayuki Kondo; Peter Davies; Mark Burns; Ralph A. Nixon; dennis dickson; Yasuji Matsuoka; Michael K Ahlijanian; Lit-Fui Lau; karen duff
Cdk5 is a key factor in tau aggregation and tangle formation in vivo.
Neuron 2003;38(4):555-65.
2003: Takashi Ishizawa; Petri Mattila; Peter Davies; Dengshun Wang; dennis dickson
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Journal of neuropathology and experimental neurology 2003;62(4):389-97.
2002: Mony J de Leon; S Segal; Chaim Y Tarshish; Susan Desanti; Raymond Zinkowski; Pankaj D Mehta; Antonio Convit; Conrado Caraos; Henry Rusinek; Wai Hon Tsui; LA Saint Louis; John DeBernardis; Daniel Kerkman; F Qadri; A Gary; P Lesbre; Thomas Wisniewski; J Poirier; Peter Davies
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment.
Neuroscience letters 2002;333(3):183-6.
2002: Katharina Buerger; Stefan J Teipel; Raymond Zinkowski; Kaj Blennow; Hiroyuki Arai; Rolf Engel; Klaus Hofmann-Kiefer; Cheryl McCulloch; U Ptok; Reinhard Heun; Niels Andreasen; John DeBernardis; Daniel Kerkman; H- J Moeller; Peter Davies; Harald Hampel
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects.
Neurology 2002;59(4):627-9.
2002: Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Tero Tapiola; Hiroyuki Arai; Kaj Blennow; Niels Andreasen; Klaus Hofmann-Kiefer; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Russell Kohnken; Frank Padberg; Tuula Pirttilä; Mark B Schapiro; Stanley I Rapoport; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Archives of neurology 2002;59(8):1267-72.
2002: Bitao Bu; Jin Li; Peter Davies; Inez Vincent
Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(15):6515-25.
2002: Chris Conrad; Cintia Vianna; Melissa Freeman; Peter Davies
A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(11):7751-6.
2001: S Parvathy; Peter Davies; Vahram Haroutunian; Dushyant P Purohit; Kenneth L Davis; Richard C Mohs; H Park; Thomas M Moran; J Y Chan; Joseph Buxbaum
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
Archives of neurology 2001;58(12):2025-32.
2001: S Pilar Zamora-Leon; Gloria Lee; Peter Davies; Bridget Shafit-Zagardo
Binding of Fyn to MAP-2c through an SH3 binding domain. Regulation of the interaction by ERK2.
The Journal of biological chemistry 2001;276(43):39950-8.
2001: A Dranovsky; I Vincent; Luisa Gregori; Alexander L Schwarzman; D Colflesh; J Enghild; Warren J Strittmatter; Peter Davies; Dmitry Goldgaber
Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.
Neurobiology of aging 2001;22(4):517-28.
2001: Harald Hampel; Katharina Buerger; Russell Kohnken; Stefan J Teipel; Raymond Zinkowski; H- J Moeller; Stanley I Rapoport; Peter Davies
Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.
Annals of neurology 2001;49(4):545-6.
2001: Eileen H Bigio; Anne M Lipton; Shu-Hui C. Yen; Michael Hutton; M Baker; Parimala Nacharaju; Charles L White; Peter Davies; W Lin; dennis dickson
Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia.
Journal of neuropathology and experimental neurology 2001;60(4):328-41.
2000: C L Weaver; M Espinoza; Yvonne Kress; Peter Davies
Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
Neurobiology of aging 2000;21(5):719-27.
2000: K Ishizawa; Hanna Ksiezak-Reding; Peter Davies; André Delacourte; P Tiseo; Shu-Hui C. Yen; dennis dickson
A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Acta neuropathologica 2000;100(3):235-44.
2000: Jada Lewis; Eileen McGowan; J Rockwood; Heather L Melrose; Parimala Nacharaju; M van Slegtenhorst; Katrina Gwinn-Hardy; M Paul Murphy; Matt Baker; X Yu; karen duff; John Hardy; A Corral; Wen-Lang Lin; Shu-Hui C. Yen; dennis dickson; Peter Davies; Michael Hutton
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Nature genetics 2000;25(4):402-5.
2000: Russell Kohnken; Katharina Buerger; Raymond Zinkowski; C Miller; Daniel Kerkman; John DeBernardis; J Shen; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.
Neuroscience letters 2000;287(3):187-90.
2000: K Ishizawa; Wen-Lang Lin; P Tiseo; William Honer; Peter Davies; dennis dickson
A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy.
Journal of neuropathology and experimental neurology 2000;59(6):513-24.
2000: Howard A Crystal; dennis dickson; Peter Davies; D Masur; E Grober; richard lipton
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians.
Archives of neurology 2000;57(5):713-9.
2000: karen duff; H Knight; Lorenzo M Refolo; S Sanders; X Yu; M Picciano; Brian Malester; Michael Hutton; J Adamson; Michel Goedert; K Burki; Peter Davies
Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes.
Neurobiology of disease 2000;7(2):87-98.
2000: J Näslund; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis; Peter Davies; Paul Greengard; Joseph Buxbaum
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
JAMA : the journal of the American Medical Association 2000;283(12):1571-7.
2000: Bridget Shafit-Zagardo; Peter Davies; JM Rockwood; Yvonne Kress; Sunhee C Lee
Novel microtubule-associated protein-2 isoform is expressed early in human oligodendrocyte maturation.
Glia 2000;29(3):233-45.
2000: Peter Davies
Characterization and use of monoclonal antibodies to tau and paired helical filament tau.
Methods in molecular medicine 2000;32():361-73.
2000: Peter Davies
A very incomplete comprehensive theory of Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;924():8-16.
2000: Cathy Andorfer; Peter Davies
PKA phosphorylations on tau: developmental studies in the mouse.
Developmental neuroscience 2000;22(4):303-9.
1999: Gregory A Jicha; C Weaver; E Lane; Cintia Vianna; Yvonne Kress; JM Rockwood; Peter Davies
cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1999;19(17):7486-94.
1999: Pei-Jung Lu; Gerburg Wulf; Xiao Zhen Zhou; Peter Davies; Kun Ping Lu
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.
Nature 1999;399(6738):784-8.
1999: Peter Davies
Challenging the cholinergic hypothesis in Alzheimer disease.
JAMA : the journal of the American Medical Association 1999;281(15):1433-4.
1999: Gregory A Jicha; B Berenfeld; Peter Davies
Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease.
Journal of neuroscience research 1999;55(6):713-23.
1999: Henry Houlden; Patrizia Rizzu; M Stevens; P de Knijff; C.M. Duijn; John C van Swieten; Peter Heutink; Jordi Perez-Tur; V Thomas; Matt Baker; H Morris; Martin N Rossor; J C Jannsen; Ronald C. Petersen; P Dodd; F Dark; Bradley Boeve; dennis dickson; Peter Davies; Stuart Pickering-Brown; D M A Mann; Jennifer Adamson; Timothy Lynch; Haydeh Payami; John Hardy
Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations.
Neuroscience letters 1999;260(3):193-5.
1999: Gregory A Jicha; JM Rockwood; B Berenfeld; Michael Hutton; Peter Davies
Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins.
Neuroscience letters 1999;260(3):153-6.
1999: Gregory A Jicha; A O'Donnell; C Weaver; Ruth Hogue Angeletti; Peter Davies
Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase.
Journal of neurochemistry 1999;72(1):214-24.
1998: Peter Friedhoff; Martin von Bergen; Eva-Maria Mandelkow; Peter Davies; Eckhard Mandelkow
A nucleated assembly mechanism of Alzheimer paired helical filaments.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(26):15712-7.
1998: Peter Davies; Brian H Anderton; J Kirsch; A Konnerth; R Nitsch; M Sheetz
First one in, last one out: the role of gabaergic transmission in generation and degeneration.
Progress in neurobiology 1998;55(6):651-8.
1998: Brian H Anderton; L Callahan; Paul D. Coleman; Peter Davies; D Flood; Gregory A Jicha; T Ohm; C Weaver
Dendritic changes in Alzheimer's disease and factors that may underlie these changes.
Progress in neurobiology 1998;55(6):595-609.
1998: Inez Vincent; J H Zheng; dennis dickson; Yvonne Kress; Peter Davies
Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease.
Neurobiology of aging 1998;19(4):287-96.
1998: Michael Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; Andrew Grover; J Hackett; J Adamson; Sarah J Lincoln; dennis dickson; Peter Davies; Ronald C. Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; John C Morris; L A Reed; John Q Trojanowski; Hans Basun; Lars Lannfelt; M Neystat; Stanley Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; David Neary; F Owen; B A Oostra; John Hardy; Alison Goate; J van Swieten; D M A Mann; T Lynch; Peter Heutink
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.
Nature 1998;393(6686):702-5.
1998: Susan J Vannucci; R R Clark; EM Koehler-Stec; K Li; C B Smith; Peter Davies; F Maher; Ian A Simpson
Glucose transporter expression in brain: relationship to cerebral glucose utilization.
Developmental neuroscience 1998;20(4-5):369-79.
1997: J Payne; F Maher; I Simpson; L Mattice; Peter Davies
Glucose transporter Glut 5 expression in microglial cells.
Glia 1997;21(3):327-31.
1997: Gregory A Jicha; E Lane; Inez Vincent; L Otvos; R Hoffmann; Peter Davies
A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
Journal of neurochemistry 1997;69(5):2087-95.
1997: Katsuyoshi Mizukami; Milos D Ikonomovic; Dennis Grayson; R T Rubin; D Warde; Roxanne Sheffield; R L Hamilton; Peter Davies; David M Armstrong
Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes.
Experimental neurology 1997;147(2):333-45.
1997: Milos D Ikonomovic; Katsuyoshi Mizukami; Peter Davies; R Hamilton; Roxanne Sheffield; David M Armstrong
The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains.
Journal of neuropathology and experimental neurology 1997;56(9):1018-27.
1997: SM Gabriel; Vahram Haroutunian; Peter Powchik; William Honer; Michael Davidson; Peter Davies; Kenneth L Davis
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Archives of general psychiatry 1997;54(6):559-66.
1997: Gregory A Jicha; R Bowser; I G Kazam; Peter Davies
Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.
Journal of neuroscience research 1997;48(2):128-32.
1997: Bridget Shafit-Zagardo; N Kalcheva; dennis dickson; Peter Davies; Yvonne Kress
Distribution and subcellular localization of high-molecular-weight microtubule-associated protein-2 expressing exon 8 in brain and spinal cord.
Journal of neurochemistry 1997;68(2):862-73.
1996: S Schoonover; Peter Davies; Robert Bowser
Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease.
Journal of neuropathology and experimental neurology 1996;55(4):444-55.
1996: Winfried Edelmann; M Zervas; P Costello; L Roback; I Fischer; J A Hammarback; N Cowan; Peter Davies; B Wainer; Raju Kucherlapati
Neuronal abnormalities in microtubule-associated protein 1B mutant mice.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(3):1270-5.
1996: Inez Vincent; M Rosado; Peter Davies
Mitotic mechanisms in Alzheimer's disease?
The Journal of cell biology 1996;132(3):413-25.
1996: dennis dickson; M B Feany; Shu-Hui C. Yen; L A Mattiace; Peter Davies
Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
Journal of neural transmission. Supplementum 1996;47():31-46.
1996: John H Xuereb; J C MacMillan; R Snell; Peter Davies; Peter S Harper
Neuropathological diagnosis and CAG repeat expansion in Huntington's disease.
Journal of neurology, neurosurgery, and psychiatry 1996;60(1):78-81.
1995: Hanna Ksiezak-Reding; R L Leibowitz; R Bowser; Peter Davies
Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins.
Brain research 1995;697(1-2):63-75.
1995: dennis dickson; H A Crystal; C Bevona; William Honer; Inez Vincent; Peter Davies
Correlations of synaptic and pathological markers with cognition of the elderly.
Neurobiology of aging 1995;16(3):285-98; discussion 298-304.
1995: J C MacMillan; Peter Davies; Peter S Harper
Molecular diagnostic analysis for Huntington's disease: a prospective evaluation.
Journal of neurology, neurosurgery, and psychiatry 1995;58(4):496-8.
1995: Carol F Lippa; T W Smith; Ann M Saunders; R Crook; D Pulaski-Salo; Peter Davies; John Hardy; Allen D Roses; dennis dickson
Apolipoprotein E genotype and Lewy body disease.
Neurology 1995;45(1):97-103.
1995: R Bowser; A Giambrone; Peter Davies
FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain.
Developmental neuroscience 1995;17(1):20-37.
1994: Inez Vincent; L A Mattiace; dennis dickson; M Rosado; R Katen; Peter Davies
TG-1: a marker for neuronal nuclei in Alzheimer's disease.
Neurobiology of disease 1994;1(3):145-57.
1994: Hanna Ksiezak-Reding; K Morgan; L A Mattiace; Peter Davies; W K Liu; Shu-Hui C. Yen; Karen M Weidenheim; dennis dickson
Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.
The American journal of pathology 1994;145(6):1496-508.
1994: I A Simpson; Peter Davies
Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease.
Annals of neurology 1994;36(5):800-1.
1994: Ian A Simpson; K R Chundu; T Davies-Hill; William Honer; Peter Davies
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.
Annals of neurology 1994;35(5):546-51.
1994: Inez Vincent; M Rosado; E Kim; Peter Davies
Increased production of paired helical filament epitopes in a cell culture system reduces the turnover of tau.
Journal of neurochemistry 1994;62(2):715-23.
1994: dennis dickson; Peter Davies; C Bevona; KH van Hoeven; Stephen M Factor; Ellen Grober; M K Aronson; H A Crystal
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.
Acta neuropathologica 1994;88(3):212-21.
1994: Peter Davies
Strategies for the development of therapeutics for Alzheimer's disease.
Neurobiology of aging 1994;15 Suppl 2():S53-4.
1993: D B Rye; James B Leverenz; S G Greenberg; Peter Davies; C B Saper
The distribution of Alz-50 immunoreactivity in the normal human brain.
Neuroscience 1993;56(1):109-27.
1993: R G Snell; J C MacMillan; Jeremy P Cheadle; Iain Fenton; Lazarus Lazarou; Peter Davies; Marcy E MacDonald; James Gusella; Peter S Harper; D J Shaw
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.
Nature genetics 1993;4(4):393-7.
1993: C Arias; N Sharma; Peter Davies; Bridget Shafit-Zagardo
Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons.
Journal of neurochemistry 1993;61(2):673-82.
1993: William Honer; L Hu; Peter Davies
Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex.
Brain research 1993;609(1-2):9-20.
1992: Peter Davies
Alz 50 as a reagent to assess animal models of Alzheimer's disease.
Neurobiology of aging 1992;13(5):613-4.
1992: S L Minger; Peter Davies
Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. I. Morphometric analysis.
Experimental neurology 1992;117(2):124-38.
1992: S L Minger; Peter Davies
Persistent innervation of the rat neocortex by basal forebrain cholinergic neurons despite the massive reduction of cortical target neurons. II. Neurochemical analysis.
Experimental neurology 1992;117(2):139-50.
1992: William Honer; dennis dickson; J Gleeson; Peter Davies
Regional synaptic pathology in Alzheimer's disease.
Neurobiology of aging 1992;13(3):375-82.
1992: V Licameli; L A Mattiace; J Erlichman; Peter Davies; dennis dickson; Bridget Shafit-Zagardo
Regional localization of the regulatory subunit (RII beta) of the type II cAMP-dependent protein kinase in human brain.
Brain research 1992;578(1-2):61-8.
1992: Inez Vincent; Peter Davies
A protein kinase associated with paired helical filaments in Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(7):2878-82.
1992: William Honer; C A Kaufmann; Peter Davies
Characterization of a synaptic antigen of interest in neuropsychiatric illness.
Biological psychiatry 1992;31(2):147-58.
1992: S G Greenberg; Peter Davies; J D Schein; L I Binder
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.
The Journal of biological chemistry 1992;267(1):564-9.
1992: S J Weber; R B Louis; L Trombley; Garth Bissette; Peter Davies; Thomas P Davis
Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease.
Journal of gerontology 1992;47(1):B18-25.
1992: dennis dickson; H A Crystal; L A Mattiace; D M Masur; A D Blau; Peter Davies; Shu-Hui C. Yen; M K Aronson
Identification of normal and pathological aging in prospectively studied nondemented elderly humans.
Neurobiology of aging 1992;13(1):179-89.
1992: dennis dickson; Hanna Ksiezak-Reding; W K Liu; Peter Davies; A Crowe; Shu-Hui C. Yen
Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
Acta neuropathologica 1992;84(6):596-605.
1991: L A Mattiace; Yvonne Kress; Peter Davies; Hanna Ksiezak-Reding; Shu-Hui C. Yen; dennis dickson
Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains.
Journal of neuropathology and experimental neurology 1991;50(5):547-59.
1991: dennis dickson; D Ruan; H Crystal; M H Mark; Peter Davies; Yvonne Kress; Shu-Hui C. Yen
Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD.
Neurology 1991;41(9):1402-9.
1991: W Byne; L Mattiace; Yvonne Kress; Peter Davies
Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat.
The Journal of comparative neurology 1991;306(4):602-12.
1991: Peter Davies
Alzheimer's disease: progress toward diagnosis in vivo.
Geriatrics 1991;46(3):79-81.
1991: Peter Davies
Therapy for Alzheimer's disease: choosing a target.
Clinical neuropharmacology 1991;14 Suppl 1():S24-33.
1990: I J Vincent; Peter Davies
Phosphorylation characteristics of the A68 protein in Alzheimer's disease.
Brain research 1990;531(1-2):127-35.
1990: H A Crystal; dennis dickson; J E Lizardi; Peter Davies; L I Wolfson
Antemortem diagnosis of diffuse Lewy body disease.
Neurology 1990;40(10):1523-8.
1990: S G Greenberg; Peter Davies
A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(15):5827-31.
1990: H A Ghanbari; B E Miller; H J Haigler; M Arato; Garth Bissette; Peter Davies; Charles Nemeroff; Elaine K Perry; Robert H Perry; Rivka Ravid
Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study.
JAMA : the journal of the American Medical Association 1990;263(21):2907-10.
1990: I J Vincent; Peter Davies
ATP-induced loss of Alz-50 immunoreactivity with the A68 proteins from Alzheimer brain is mediated by ubiquitin.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(12):4840-4.
1990: L A Mattiace; Peter Davies; dennis dickson
Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.
The American journal of pathology 1990;136(5):1101-14.
1990: William J Jagust; Peter Davies; J K Tiller-Borcich; Bruce R Reed
Focal Alzheimer's disease.
Neurology 1990;40(1):14-9.
1990: L A Mattiace; Peter Davies; Shu-Hui C. Yen; dennis dickson
Microglia in cerebellar plaques in Alzheimer's disease.
Acta neuropathologica 1990;80(5):493-8.
1990: dennis dickson; A Wertkin; L A Mattiace; E Fier; Yvonne Kress; Peter Davies; Shu-Hui C. Yen
Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease.
Acta neuropathologica 1990;79(5):486-93.
1989: William Honer; C A Kaufmann; J E Kleinman; M F Casanova; Peter Davies
Monoclonal antibodies to study the brain in schizophrenia.
Brain research 1989;500(1-2):379-83.
1989: Peter Davies
A different view of A68 and amyloid.
Neurobiology of aging 1989;10(5):408-9; discussion 412-4.
1989: Diana Casper; Peter Davies
Mechanism of activation of choline acetyltransferase in a human neuroblastoma cell line.
Brain research 1989;478(1):85-94.
1989: Diana Casper; Peter Davies
Stimulation of choline acetyltransferase activity by retinoic acid and sodium butyrate in a cultured human neuroblastoma.
Brain research 1989;478(1):74-84.
1989: dennis dickson; H Crystal; L A Mattiace; Yvonne Kress; A Schwagerl; Hanna Ksiezak-Reding; Peter Davies; Shu-Hui C. Yen
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.
Acta neuropathologica 1989;78(6):572-84.
1989: H Crystal; Peter Davies; dennis dickson; Angela Scicutella; A Blau; D Masur
Neuropsychological characteristics of subjects with and without neocortical Alz-50 immunoreactivity.
Progress in clinical and biological research 1989;317():165-73.
1988: L C Cork; R E Powers; Dennis J Selkoe; Peter Davies; J J Geyer; Donald L Price
Neurofibrillary tangles and senile plaques in aged bears.
Journal of neuropathology and experimental neurology 1988;47(6):629-41.
1988: Massimo Tabaton; Peter J Whitehouse; George Perry; Peter Davies; L Autilio-Gambetti; Pierluigi Gambetti
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
Annals of neurology 1988;24(3):407-13.
1988: Benjamin Wolozin; Angela Scicutella; Peter Davies
Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer disease.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(16):6202-6.
1988: Angela Scicutella; Peter Davies
Characterization of monoclonal antibodies to galactolipids and uses in studies of dementia.
Journal of neuropathology and experimental neurology 1988;47(4):406-19.
1988: dennis dickson; J Farlo; Peter Davies; H Crystal; P Fuld; Shu-Hui C. Yen
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.
The American journal of pathology 1988;132(1):86-101.
1988: Hanna Ksiezak-Reding; Peter Davies; Shu-Hui C. Yen
Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain.
The Journal of biological chemistry 1988;263(17):7943-7.
1988: Peter Davies
Neurochemical studies: an update on Alzheimer's disease.
The Journal of clinical psychiatry 1988;49 Suppl():23-8.
1988: Bradley T Hyman; Gary W Van Hoesen; Benjamin Wolozin; Peter Davies; L J Kromer; Antonio R Damasio
Alz-50 antibody recognizes Alzheimer-related neuronal changes.
Annals of neurology 1988;23(4):371-9.
1988: B R Zisman; V Braunstein; Y Kress; Peter Davies
Effects of persistent lymphocytic choriomeningitis virus infection on cholinergic neurons in the mouse.
Neurobiology of aging 1988;9(2):207-12.
1988: Robert Katzman; R Terry; R DeTeresa; T Brown; Peter Davies; P Fuld; X Renbing; A Peck
Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.
Annals of neurology 1988;23(2):138-44.
1988: Lawrence A Hansen; R DeTeresa; Peter Davies; R D Terry
Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.
Neurology 1988;38(1):48-54.
1988: Diana Casper; Peter Davies
Regulation of choline acetyltransferase activity by cell density in a cultured human neuroblastoma cell line.
Developmental neuroscience 1988;10(4):245-55.
1988: J A Doebler; William R Markesbery; A Anthony; Peter Davies; Stephen W Scheff; R E Rhoads
Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
Annals of neurology 1988;23(1):20-4.
1987: Leon J Thal; Peter Davies
Detection of antigens in Alzheimer cerebrospinal fluid by monoclonal antibodies.
Journal of the American Geriatrics Society 1987;35(12):1047-50.
1987: Angela Scicutella; Peter Davies
Marked loss of cerebral galactolipids in Pick's disease.
Annals of neurology 1987;22(5):606-9.
1987: Benjamin Wolozin; Peter Davies
Alzheimer-related neuronal protein A68: specificity and distribution.
Annals of neurology 1987;22(4):521-6.
1987: Mark F Mehler; D S Horoupian; Peter Davies; dennis dickson
Reduced somatostatin-like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia.
Neurology 1987;37(9):1448-53.
1987: Peter Davies; Benjamin Wolozin
Recent advances in the neurochemistry of Alzheimer's disease.
The Journal of clinical psychiatry 1987;48 Suppl():23-30.
1987: R D Terry; Lawrence A Hansen; R DeTeresa; Peter Davies; H Tobias; Robert Katzman
Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles.
Journal of neuropathology and experimental neurology 1987;46(3):262-8.
1987: Hanna Ksiezak-Reding; dennis dickson; Peter Davies; Shu-Hui C. Yen
Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(10):3410-4.
1987: dennis dickson; Peter Davies; Richard Mayeux; H Crystal; D S Horoupian; A Thompson; J E Goldman
Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients.
Acta neuropathologica 1987;75(1):8-15.
1987: dennis dickson; Hanna Ksiezak-Reding; Peter Davies; Shu-Hui C. Yen
A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration.
Acta neuropathologica 1987;73(3):254-8.
1986: Peter Davies
The genetics of Alzheimer's disease: a review and a discussion of the implications.
Neurobiology of aging 1986;7(6):459-66.
1986: dennis dickson; D S Horoupian; Leon J Thal; Peter Davies; Steven U Walkley; R D Terry
Klüver-Bucy syndrome and amyotrophic lateral sclerosis: a case report with biochemistry, morphometrics, and Golgi study.
Neurology 1986;36(10):1323-9.
1986: Benjamin Wolozin; A Pruchnicki; dennis dickson; Peter Davies
A neuronal antigen in the brains of Alzheimer patients.
Science (New York, N.Y.) 1986;232(4750):648-50.
1986: Leon J Thal; D M Masur; N S Sharpless; P A Fuld; Peter Davies
Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease.
Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):627-36.
1986: Robert Katzman; T Brown; P Fuld; Leon J Thal; Peter Davies; R Terry
Significance of neurotransmitter abnormalities in Alzheimer's disease.
Research publications - Association for Research in Nervous and Mental Disease 1986;64():279-86.
1986: Charles Marotta; R E Majocha; J F Coughlin; H J Manz; Peter Davies; M Ventosa-Michelman; W G Chou; S B Zain; E M Sajdel-Sulkowska
Transcriptional and translational regulatory mechanisms during normal aging of the mammalian brain and in Alzheimer's disease.
Progress in brain research 1986;70():303-20.
1986: dennis dickson; Shu-Hui C. Yen; K I Suzuki; Peter Davies; JH Garcia; Asao Hirano
Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes.
Acta neuropathologica 1986;71(3-4):216-23.
1985: Leon J Thal; N S Sharpless; D Rosenbaum; Peter Davies; I M Amin; J M Waltz
Ventricular fluid somatostatin concentration decreases in childhood-onset dystonia.
Neurology 1985;35(12):1742-6.
1985: N R Cutler; L L Heston; Peter Davies; J V Haxby; Mark B Schapiro
NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
Annals of internal medicine 1985;103(4):566-78.
1985: Peter Davies
A critical review of the role of the cholinergic system in human memory and cognition.
Annals of the New York Academy of Sciences 1985;444():212-7.
1984: D A Katz; A Naseem; D S Horoupian; A D Rothner; Peter Davies
Familial multisystem atrophy with possible thalamic dementia.
Neurology 1984;34(9):1213-7.
1984: D S Horoupian; Leon J Thal; Robert Katzman; R D Terry; Peter Davies; Asao Hirano; R DeTeresa; P A Fuld; Carol K Petito; J Blass
Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies.
Annals of neurology 1984;16(3):305-13.
1983: Peter Davies
The neurochemistry of Alzheimer's disease and senile dementia.
Medicinal research reviews 1983;3(3):221-36.
1983: Herbert B Tanowitz; Peter Davies; M Wittner
Alterations in acetylcholine receptors in experimental chagas' disease.
The Journal of infectious diseases 1983;147(3):460-6.
1983: Leon J Thal; P A Fuld; D M Masur; N S Sharpless; Peter Davies
Oral physostigmine and lecithin improve memory in Alzheimer's disease.
Psychopharmacology bulletin 1983;19(3):454-6.
1983: Peter Davies
An update on the neurochemistry of Alzheimer disease.
Advances in neurology 1983;38():75-86.
1982: Peter Davies; S Feisullin
A search for discrete cholinergic nuclei in the human ventral forebrain.
Journal of neurochemistry 1982;39(6):1743-7.
1982: M McKinney; Peter Davies; J T Coyle
Somatostatin is not co-localized in cholinergic neurons innervating the rat cerebral cortex-hippocampal formation.
Brain research 1982;243(1):169-72.
1982: H A Crystal; Peter Davies
Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Journal of neurochemistry 1982;38(6):1781-4.
1982: P A Fuld; Robert Katzman; Peter Davies; R D Terry
Intrusions as a sign of Alzheimer dementia: chemical and pathological verification.
Annals of neurology 1982;11(2):155-9.
1981: Peter Davies; J Josef; A Thompson
Anterior to posterior variations in the concentration of somatostatin-like immunoreactivity in human basal ganglia.
Brain research bulletin 1981;7(4):365-8.
1981: Peter Davies; S Feisullin
Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain.
Brain research 1981;216(2):449-54.
1981: Peter Davies; A Thompson
Postmortem stability of somatostatin-like immunoreactivity in mouse brain under conditions simulating handling of human autopsy material.
Neurochemical research 1981;6(7):787-91.
1981: Herbert B Tanowitz; Peter Davies; Stephen M Factor; T Minase; A Herskowitz; M Wittner
Trypanosoma cruzi: choline acetyltransferase activity in tissues of susceptible and resistant mice infected with the Brazil strain.
Experimental parasitology 1981;51(2):269-78.
1981: Peter Davies; R D Terry
Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Neurobiology of aging 1981;2(1):9-14.
1980: Peter Davies; Robert Katzman; R D Terry
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
Nature 1980;288(5788):279-80.
1980: R D Terry; Peter Davies
Dementia of the Alzheimer type.
Annual review of neuroscience 1980;3():77-95.
1979: Peter Davies
Neurotransmitter-related enzymes in senile dementia of the Alzheimer type.
Brain research 1979;171(2):319-27.
1979: Peter Davies
Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
Research publications - Association for Research in Nervous and Mental Disease 1979;57():153-66.
1978: A V Mackay; C M Yates; A Wright; P Hamilton; Peter Davies
Regional distribution of monoamines and their metabolites in the human brain.
Journal of neurochemistry 1978;30(4):841-8.
1978: A V Mackay; Peter Davies; A J Dewar; C M Yates
Regional distribution of enzymes associated with neurotransmission by monoamines, acetylcholine and GABA in the human brain.
Journal of neurochemistry 1978;30(4):827-39.
1978: Peter Davies
Loss of choline acetyltransferase activity in normal aging and in senile dementia.
Advances in experimental medicine and biology 1978;113():251-6.
1977: Peter Davies; A H Verth
Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.
Brain research 1977;138(2):385-92.
1976: Peter Davies; A J Maloney
Selective loss of central cholinergic neurons in Alzheimer's disease.
Lancet 1976;2(8000):1403.